These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 1719749)
1. Immunopharmacology and immunotoxicology. Hadden JW Adv Exp Med Biol; 1991; 288():1-11. PubMed ID: 1719749 [No Abstract] [Full Text] [Related]
2. [Treatment of the primary immunodeficiency diseases. Present state of the art (author's transl)]. Fontán G; García Rodríguez MC; Ojeda JA An Esp Pediatr; 1981 Dec; 15(6):563-72. PubMed ID: 6175263 [No Abstract] [Full Text] [Related]
3. [Immunotherapy today. II. Immunostimulating therapy]. D'Amelio R Riv Med Aeronaut Spaz; 1978; 41(1):75-114. PubMed ID: 93770 [No Abstract] [Full Text] [Related]
4. Immunotherapy in acquired immune deficiency syndrome and related syndromes. Byrom NA J Hosp Infect; 1985 Dec; 6 Suppl C():43-52. PubMed ID: 2418104 [No Abstract] [Full Text] [Related]
9. Immunopharmacologic bases of immunotherapy. Hadden JW; Keskiner Merriam L Clin Physiol Biochem; 1985; 3(2-3):111-9. PubMed ID: 2408810 [TBL] [Abstract][Full Text] [Related]
10. [Immunomodulating treatment of patients with HIV infection]. Skotnicki AB; Kornaszewski W Przegl Dermatol; 1989; 76(4):285-91. PubMed ID: 2483589 [No Abstract] [Full Text] [Related]
11. Patients with impaired immune status treated with the immunomodulating drug isoprinosine. Zlatev S; Haydoushka I; Batinova S Folia Med (Plovdiv); 1989; 31(4):16-23. PubMed ID: 2484984 [No Abstract] [Full Text] [Related]
12. Immunotoxicology: overview and future perspectives. Bellanti JA Ann Allergy; 1991 Jun; 66(6):465-73. PubMed ID: 2048761 [No Abstract] [Full Text] [Related]
13. Thymic hormone in the treatment of cancer. Dardeene M; Bach JF Prog Clin Biol Res; 1989; 288():363-82. PubMed ID: 2654955 [No Abstract] [Full Text] [Related]
15. [Principles of using immunostimulants for correction of immunologic deficiency in pollinosis]. Kravchuk GP; Zabolotnyĭ DI; Begunova TI Vestn Otorinolaringol; 1979; (6):53-6. PubMed ID: 316218 [No Abstract] [Full Text] [Related]
17. A review of immunomodulators and their application in veterinary medicine. Mulcahy G; Quinn PJ J Vet Pharmacol Ther; 1986 Jun; 9(2):119-39. PubMed ID: 2425099 [No Abstract] [Full Text] [Related]
18. Therapy of secondary T-cell immunodeficiencies with biological substances and drugs. Hadden JW; Hadden EM Med Oncol Tumor Pharmacother; 1989; 6(1):11-7. PubMed ID: 2657244 [TBL] [Abstract][Full Text] [Related]
19. Immunologic reconstitution with bone marrow transplantation and thymic hormones in two patients with severe pure T-cell defects. Businco L; Rossi P; Paganelli R; Seminara R; Aiuti F Birth Defects Orig Artic Ser; 1983; 19(3):281-5. PubMed ID: 6360241 [No Abstract] [Full Text] [Related]
20. Age- and disease-related decline in immune function: an opportunity for "thymus-boosting" therapies. Berthiaume F; Aparicio CL; Eungdamrong J; Yarmush ML Tissue Eng; 1999 Dec; 5(6):499-514. PubMed ID: 10611542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]